sample size for partial replicate - USFDA [Power / Sample Size]

posted by niraj.bhatt – India, 2013-10-17 10:53 (4636 d 18:28 ago) – Posting: # 11669
Views: 18,846

Dear All,

We have a data of partial replicate (TRR,RRT,RTR) pilot study and we have within-subject variability of reference formulation.

Now suppose we want to estimate sample size for pivotal partial replicate (TRR,RRT,RTR) study using pilot study results.

Can we use within-subject variability of reference formulation for sample size calculation of pivotal study?

If yes, can we use observed N or should it be multiplied by 0.75 (for 3 period partial replicate study design) or 0.5 (for 4 period fully replicate study design)?

Your suggestion in this regard will be highly appreciated.

Best regards,
Niraj

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
316 visitors (0 registered, 316 guests [including 34 identified bots]).
Forum time: 05:21 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5